Quick Answer
ProMIS Neurosciences Inc. reported Diluted EPS of $22.61 per share (loss) for fiscal year 2025.
ProMIS Neurosciences Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$22.61 | -959.7% |
| 2024 | $2.63 | +345.8% |
| 2023 | -$1.07 | +55.6% |
| 2022 | -$2.41 | -42.6% |
| 2021 | -$1.69 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.24 | -177.4% | +17.2% |
| June 30, 2025 | -$0.29 | -123.1% | -38.1% |
| March 31, 2025 | -$0.21 | -10.5% | -167.7% |
| September 30, 2024 | $0.31 | +263.2% | +338.5% |
| June 30, 2024 | -$0.13 | +51.9% | +31.6% |
| March 31, 2024 | -$0.19 | +67.2% | +0.0% |
| September 30, 2023 | -$0.19 | +77.1% | +29.6% |
| June 30, 2023 | -$0.27 | +28.9% | +53.4% |
- ProMIS Neurosciences Inc. showed a decrease of -959.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, ProMIS Neurosciences Inc.’s diluted eps has declined by 1237.9% (from $1.69 per share (loss) to $22.61 per share (loss)).
- The most recent figure is from ProMIS Neurosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: